Home / News / BPR Medical secures licence to sell life-saving oxygen firebreak in Japan

BPR Medical secures licence to sell life-saving oxygen firebreak in Japan

BPR Medical’s Firesafe™ cannula valve, which can prevent patient deaths and limit injuries in the event of an oxygen fire, has been licensed for use among Japan’s 160,000 home oxygen patients.

Thousands of patients who rely on oxygen to alleviate the symptoms of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) are killed or injured every year in fires that could have been extinguished by a simple firebreak. The Firesafe cannula valve, an inexpensive device that lasts for up to four years, is placed in the oxygen tubing or cannula. A built-in thermal valve stops the flow of oxygen in the event of fire spreading down the oxygen tubing.

Marketing authorisation for the bidirectional Firesafe™ cannula valve as a Class II device in Japan was achieved through a partnership with BPR Medical’s distributor in Japan, Taiyo Nippon Sanso Corporation.

Richard Radford, Managing Director, BPR Medical, said, “It’s an unfortunate fact that up to half of home oxygen patients continue to smoke despite warnings and advice about the inherent dangers. Everyday household items, such as birthday candles, gas ovens and electrical devices, can also pose a risk to patients on oxygen therapy.

“The United Kingdom led the way by making the use of firebreaks mandatory in oxygen concentrator installations in 2006, and since then there has been an increasing recognition of the potential life-saving benefits of these devices in other parts of the world.

“The licence to market the Firesafe™ cannula valve in Japan is an important step forward in ensuring oxygen patients across the globe are afforded the same protection from fire as those in the UK and Germany where they are fitted as standard.”

Firebreaks are mandatory in the European Union and are a standard requirement on certain devices elsewhere in the world. The new European Medical Device Regulations, enacted on 26th May 2017, clarified that a firebreak device is required on all oxygen modalities, including oxygen concentrators, gaseous cylinders, and liquid oxygen Dewars and devices. Despite this, provision of firebreaks in Europe remains inconsistent.

To find out more about BPR Medical, please click here.

Check Also

£2.5bn British Patient Capital Programme Launched to Enable Long-Term Investment in Innovative Companies across the UK

The British Business Bank is launching British Patient Capital, a new £2.5bn programme designed to …